Fructose Sodium Diphosphate for Injection
Generic name: Fructose Sodium Diphosphate for Injection
English name: Fructose Sodium Diphosphate for Injection
This product is applicable to hypophosphatemia. Hypophosphatemia may occur in acute conditions, such as blood transfusion, operation under cardiopulmonary bypass, and parenteral nutrition. It is also related to the depletion of carbonic acid in chronic diseases such as chronic alcoholism, chronic malnutrition, and chronic respiratory failure.
[Specifications] (1) 2.5g (2) 5g (3) 7.5g (4) 10g (based on C6H11Na3O12P2)
[Validity period] 36 months.
[Approval number] (1) 2.5g national medicine standard word H20045124
(2) 5g national medicine quasi-word
(3) 7.5g national medicine standard word H20046550
(4) 10g national medicine quasi-word H20045125